151 related articles for article (PubMed ID: 18641686)
21. FBXW7 acts as an independent prognostic marker and inhibits tumor growth in human osteosarcoma.
Li Z; Xiao J; Hu K; Wang G; Li M; Zhang J; Cheng G
Int J Mol Sci; 2015 Jan; 16(2):2294-306. PubMed ID: 25622249
[TBL] [Abstract][Full Text] [Related]
22. NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols.
Zuurbier L; Homminga I; Calvert V; te Winkel ML; Buijs-Gladdines JG; Kooi C; Smits WK; Sonneveld E; Veerman AJ; Kamps WA; Horstmann M; Petricoin EF; Pieters R; Meijerink JP
Leukemia; 2010 Dec; 24(12):2014-22. PubMed ID: 20861909
[TBL] [Abstract][Full Text] [Related]
23. Fbxw7-dependent degradation of Notch is required for control of "stemness" and neuronal-glial differentiation in neural stem cells.
Matsumoto A; Onoyama I; Sunabori T; Kageyama R; Okano H; Nakayama KI
J Biol Chem; 2011 Apr; 286(15):13754-64. PubMed ID: 21349854
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of fibroblast growth by Notch1 signaling is mediated by induction of Wnt11-dependent WISP-1.
Liu ZJ; Li Y; Tan Y; Xiao M; Zhang J; Radtke F; Velazquez OC
PLoS One; 2012; 7(6):e38811. PubMed ID: 22715413
[TBL] [Abstract][Full Text] [Related]
25. Loss of Fbxw7 triggers mammary tumorigenesis associated with E2F/c-Myc activation and Trp53 mutation.
Meyer AE; Furumo Q; Stelloh C; Minella AC; Rao S
Neoplasia; 2020 Nov; 22(11):644-658. PubMed ID: 33070870
[TBL] [Abstract][Full Text] [Related]
26. NOTCH1 and FBXW7 mutations favor better outcome in pediatric South Indian T-cell acute lymphoblastic leukemia.
Natarajan V; Bandapalli OR; Rajkumar T; Sagar TG; Karunakaran N
J Pediatr Hematol Oncol; 2015 Jan; 37(1):e23-30. PubMed ID: 25493453
[TBL] [Abstract][Full Text] [Related]
27. F-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous manner.
Yumimoto K; Akiyoshi S; Ueo H; Sagara Y; Onoyama I; Ueo H; Ohno S; Mori M; Mimori K; Nakayama KI
J Clin Invest; 2015 Feb; 125(2):621-35. PubMed ID: 25555218
[TBL] [Abstract][Full Text] [Related]
28. It's T-ALL about Notch.
Demarest RM; Ratti F; Capobianco AJ
Oncogene; 2008 Sep; 27(38):5082-91. PubMed ID: 18758476
[TBL] [Abstract][Full Text] [Related]
29. Identification of novel NOTCH1 mutations: increasing our knowledge of the NOTCH signaling pathway.
Gallo Llorente L; Luther H; Schneppenheim R; Zimmermann M; Felice M; Horstmann MA
Pediatr Blood Cancer; 2014 May; 61(5):788-96. PubMed ID: 24249312
[TBL] [Abstract][Full Text] [Related]
30. The Fbxw7/hCdc4 tumor suppressor in human cancer.
Tan Y; Sangfelt O; Spruck C
Cancer Lett; 2008 Nov; 271(1):1-12. PubMed ID: 18541364
[TBL] [Abstract][Full Text] [Related]
31. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
[TBL] [Abstract][Full Text] [Related]
32. Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesis.
Wang J; Wang H; Peters M; Ding N; Ribback S; Utpatel K; Cigliano A; Dombrowski F; Xu M; Chen X; Song X; Che L; Evert M; Cossu A; Gordan J; Zeng Y; Chen X; Calvisi DF
J Hepatol; 2019 Oct; 71(4):742-752. PubMed ID: 31195063
[TBL] [Abstract][Full Text] [Related]
33. The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling.
Malyukova A; Dohda T; von der Lehr N; Akhoondi S; Corcoran M; Heyman M; Spruck C; Grandér D; Lendahl U; Sangfelt O
Cancer Res; 2007 Jun; 67(12):5611-6. PubMed ID: 17575125
[TBL] [Abstract][Full Text] [Related]
34. Regulation mechanism of Fbxw7-related signaling pathways (Review).
Zhou Z; He C; Wang J
Oncol Rep; 2015 Nov; 34(5):2215-24. PubMed ID: 26324296
[TBL] [Abstract][Full Text] [Related]
35. FBXW7 mutations in melanoma and a new therapeutic paradigm.
Aydin IT; Melamed RD; Adams SJ; Castillo-Martin M; Demir A; Bryk D; Brunner G; Cordon-Cardo C; Osman I; Rabadan R; Celebi JT
J Natl Cancer Inst; 2014 Jun; 106(6):dju107. PubMed ID: 24838835
[TBL] [Abstract][Full Text] [Related]
36. The FBXW7 beta-form is suppressed in human glioma cells.
Gu Z; Inomata K; Ishizawa K; Horii A
Biochem Biophys Res Commun; 2007 Mar; 354(4):992-8. PubMed ID: 17274947
[TBL] [Abstract][Full Text] [Related]
37. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X
Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992
[TBL] [Abstract][Full Text] [Related]
38. Decreased growth of Vhl-/- fibrosarcomas is associated with elevated levels of cyclin kinase inhibitors p21 and p27.
Mack FA; Patel JH; Biju MP; Haase VH; Simon MC
Mol Cell Biol; 2005 Jun; 25(11):4565-78. PubMed ID: 15899860
[TBL] [Abstract][Full Text] [Related]
39. RNAi screen reveals synthetic lethality between cyclin G-associated kinase and FBXW7 by inducing aberrant mitoses.
Dolly SO; Gurden MD; Drosopoulos K; Clarke P; de Bono J; Kaye S; Workman P; Linardopoulos S
Br J Cancer; 2017 Sep; 117(7):954-964. PubMed ID: 28829765
[TBL] [Abstract][Full Text] [Related]
40. Notch1 and 2 cooperate in limb ectoderm to receive an early Jagged2 signal regulating interdigital apoptosis.
Pan Y; Liu Z; Shen J; Kopan R
Dev Biol; 2005 Oct; 286(2):472-82. PubMed ID: 16169548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
